Senvest Capital
Senvest Capital operates as a holding company focused on investment management and direct investments in public securities and private assets. Established in 1997 and headquartered in Montreal, Canada, with additional offices in New York and Los Angeles, the firm primarily invests in value stocks and employs various analytical approaches, including fundamental and quantitative analysis. Senvest Capital manages a diverse portfolio that includes equity and real estate investments predominantly in the United States, with additional holdings in Spain and Argentina. It also caters to institutions and high-net-worth individuals through targeted funds. Originally founded as a distributor for Sensormatic Electronics, the company has a history of engaging in various businesses, including operating one of Canada’s first cable pay-TV channels.
Bigfoot Biomedical, Inc., a health solution company, develops automated insulin delivery systems for people with Type 1 Diabetes (T1D). It develops a T1D Management System with cloud connectivity and human-centered-automation; and insulin pumps. Bigfoot Biomedical, Inc. was formerly known as SmartLoop Labs, Inc. and changed its name to in Bigfoot Biomedical, Inc. February 2015. The company was incorporated in 2014 and is based in Milpitas, California.
Bigfoot Biomedical, Inc., a health solution company, develops automated insulin delivery systems for people with Type 1 Diabetes (T1D). It develops a T1D Management System with cloud connectivity and human-centered-automation; and insulin pumps. Bigfoot Biomedical, Inc. was formerly known as SmartLoop Labs, Inc. and changed its name to in Bigfoot Biomedical, Inc. February 2015. The company was incorporated in 2014 and is based in Milpitas, California.
Bigfoot Biomedical, Inc., a health solution company, develops automated insulin delivery systems for people with Type 1 Diabetes (T1D). It develops a T1D Management System with cloud connectivity and human-centered-automation; and insulin pumps. Bigfoot Biomedical, Inc. was formerly known as SmartLoop Labs, Inc. and changed its name to in Bigfoot Biomedical, Inc. February 2015. The company was incorporated in 2014 and is based in Milpitas, California.
UNLIMITED is at the forefront in the design and creation of high-end Virtual Reality Experiences. VR is a revolutionary new medium - a mind-blowing hybrid between interactive media and immersive cinematic experiences. They offer branded and original VR content for immersive and interactive media, including films, TV series, games and advertising.
Bigfoot Biomedical, Inc., a health solution company, develops automated insulin delivery systems for people with Type 1 Diabetes (T1D). It develops a T1D Management System with cloud connectivity and human-centered-automation; and insulin pumps. Bigfoot Biomedical, Inc. was formerly known as SmartLoop Labs, Inc. and changed its name to in Bigfoot Biomedical, Inc. February 2015. The company was incorporated in 2014 and is based in Milpitas, California.
Spotify is a leading music streaming service headquartered in Stockholm, Sweden, and operates on a global scale with 602 million monthly active users as of 2023. Founded in 2006, Spotify offers an extensive catalog of music and podcasts, allowing users to access content on various devices, including computers, mobile phones, and tablets. The platform features both a premium subscription model, which provides ad-free streaming, and an ad-supported service, generating revenue from ads. In 2023, 86% of Spotify's revenue came from premium subscriptions, while 14% was derived from advertising. Users can discover music collections, create and share playlists, and receive personalized recommendations. Spotify's infrastructure supports integration with social media platforms, enabling artists to promote their music and engage with fans effectively. The company operates various subsidiaries, including Spotify India Private Limited, enhancing its presence in international markets.
Medigus Ltd. is a medical device company based in Omer, Israel, that specializes in developing and marketing innovative minimally invasive endo-surgical tools and direct visualization technology. Founded in 1999, the company primarily focuses on the treatment of gastroesophageal reflux disease (GERD), a common chronic condition. Medigus has created an endoscopic system known as the SRS, which integrates a miniaturized video camera, surgical stapler, and ultrasonic alignment sights into a single device. This system allows gastroenterologists and surgeons to perform a partial anterior fundoplication endoluminally, significantly transforming GERD treatment by reducing reliance on traditional open or laparoscopic surgeries. In addition to its proprietary products, Medigus designs and manufactures endoscopy systems for partner companies, offering a range of technologies including small video cameras, video processors, and various types of endoscopes for diverse endoscopic procedures. The company operates globally across the United States, Europe, Asia, and other international markets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.